- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Nos. 333-205471, 333-205469, 333-183491, 333-176111, 333-176110, 333-173208, 333-230644, 333-234630, 333-236542, 333-249928 and 333-261117) on Form S-8, Registration Statement (No. 333-234353) on Form S-3, and Registration Statements (Nos. 333-224424, 333-225768, 333-236572, 333-238635, and 333-249353) on Form S-1 of InVivo Therapeutics Holdings Corp. of our report dated March 7, 2022, relating to the consolidated financial statements of InVivo Therapeutics Holdings Corp. and Subsidiary, appearing in this Annual Report on Form 10-K of InVivo Therapeutics Holdings corp. for the year ended December 31, 2021.
/s/RSM US LLP
Boston, Massachusetts
March 7, 2022